A special edition of our podcast live from Copenhagen, Denmark, where we talk to Oluf Borbye Pedersen and Theis Brydegaard on all things gut, social eating and adherence.

We speak to Season Health about how they started their food-as-medicine platform, adherence, and the challenge of introducing new approaches to healthcare.

Lauren Carroll and Erin Merelli of Deathwives talk desanitising the conversation around death, planning for the end, and why confronting mortality makes for better living.

Healthcare workers are losing a sense of meaning in their work. How did we get here, and what can we do to solve this as the care system finds itself increasingly squeezed?

Millie Arora sits down with Chris Cozic, Executive Vice President & Chief People Officer at Genmab to discuss how to scale and cultivate culture.

How can a more social and cultural understanding of mental health offer better solutions to care?

Zlatko Rihter (CEO at Mölnlyck) speaks to Martin Gronemann about trusting the ethnographic process, embracing a customer-oriented approach, and uniting the worlds of business and social sciences to build strategy.

Ed Whiting (Wellcome Trust’s Director of Strategy) speaks to Mads Holme about the big organisational shifts required to deliver on Wellcome’s new strategy, how deeper, more reciprocal partnerships lead to more long-term solutions, and the importance of human understanding in both effecting change and creating equitable cultures.

A conversation between Britt Meelby Jensen, CEO of AMBU A/S & Mads Holme, Managing Partner at ReD Associates.

The COVID-19 pandemic has the potential to rip the band-aid off dysfunctional healthcare systems.

In this groundbreaking study of cancer patients treated with immunotherapy for stage IV cancer, ReD has illuminated the particular state of patients who survive longer than their initial prognosis. These patients are able to achieve a state of normalcy, despite having a terminal condition.

ReD worked with Cognizant, taking an outside-in perspective to study the phenomenon of healing.

An interview with Kristian Villumsen, a SVP at Coloplast, on how ReD helped the healthcare company innovate.

Pharmaceutical companies should take a closer look at how they create value. In a world of value-based health care, the answer goes beyond developing a new drug.

As medical understanding around body weight and related medical problems has increased, obesity has become a healthcare concern as well as an aesthetic one.

To understand and diagnose an illness requires acknowledging the ecology in which it takes place and collecting multiple perspectives.

How understanding the social, psychological, and emotional experience of psoriasis is fueling the pharmaceutical industry.

ReD facilitated Coloplast’s transition to compliance with a more micro-level approach to innovation.

ReD conducted Novo Nordisk’s first study around the emotional experience of patients living with diabetes.

Pharma companies are taking steps toward "patient-centric" healthcare by using patient insights to guide drug development and clinical trials.